Who is sponsoring NCT06147089?

NCT06147089 is sponsored by Erasmus Medical Center.

What drugs are being tested in NCT06147089?

Interventions in NCT06147089: Sleep Intervention, Nutritional intervention.

What condition does NCT06147089 study?

NCT06147089 studies Shift-Work Related Sleep Disturbance.

Is NCT06147089 still recruiting?

NCT06147089 is currently completed. Last updated 8 September 2025.

Last reviewed 2025-09-08 · How we verify

NCT06147089: GRIP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shift Work Intervention Strategies for Night Shift Workers

Completed NA Last updated 8 September 2025

What this trial tests

NA trial testing Sleep Intervention in Shift-Work Related Sleep Disturbance in 57 participants. Completed in 11 February 2025.

Timeline

9 February 2023

Primary endpoint
11 February 2025

11 February 2025

Quick facts

Lead sponsor	Erasmus Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	57
Start date	9 February 2023
Primary completion	11 February 2025
Estimated completion	11 February 2025
Sites	1 location across Netherlands

Drugs / interventions tested

Sleep Intervention
Nutritional intervention

Conditions studied

Shift-Work Related Sleep Disturbance — all drugs for Shift-Work Related Sleep Disturbance →

Sponsor

Erasmus Medical Center

Who can join

Adults 18 to 60, any sex, with Shift-Work Related Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this intervention study is to test behavioral interventions in night shift workers. The main question it aims to answer is: • Can personalized sleep or nutrition intervention strategies help against the negative health effects of night shift work? Participants will be followed before and after the intervention. Participants will wear smart devices, do a alertness/performance test and complete questionnaires. Blood samples will be collected. Researchers will compare the intervention groups to the control group (which receives no intervention) to see if the sleep and nutrition interventions affected the health of night shift workers.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Personalized sleep and nutritional strategies to combat adverse effects of night shift work: a controlled intervention protocol.
van der Rhee M, Oosterman JE, Wopereis S, van der Horst GTJ, et al · · 2024 · cited 2× · PMID 39300419 · DOI 10.1186/s12889-024-20022-w
"Feeding the Rhythm"-Effects of Food and Nutrients on Daily Cortisol Secretion: From Molecular Mechanisms to Clinical Impact.
Paragliola RM, Marchetti M, Montagna C, Corsello SM, et al · · 2025 · cited 1× · PMID 41303713 · DOI 10.3390/ijms262211230

Verify or expand the search:

Other trials of Sleep Intervention

Trials testing the same drug.

NCT07082218 — Multidimensional Sleep Health Intervention to Optimize Concussion Recovery · NA · not yet recruiting
NCT03596983 — P20 Extending Sleep to Reverse Metabolic Syndrome · NA · completed
NCT03781076 — Sleep After Adolescent Concussion · NA · completed

Other Erasmus Medical Center trials

Trials by the same sponsor.

NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06147089 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
Last refreshed: 8 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06147089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing